Natalia Romanova
Business Development Director and Co-founder @N2 Pharmaceuticals Ltd
Signup · Get unlimited contacts
WORK HISTORY
Business Development Director and Co-founder @N2 Pharmaceuticals Ltd
Medical Research Scotland PhD studentship award winners - 2020- SMART Scotland Grant winners - 2018- Animal Health Investment Europe showcase finalists - London 2018- Informa Disruptors & innovators report 2018 Top 20 Animal Health start-upsN2 Pharmaceuticals has developed and patented a proprietary method to extract bioactive peptides (N2-01) from Mytilus edulis. N2-01 has already been used in farm and companion animals and is proven to reduce mortality in multiple conditions associated with endothelial dysfunction, including Porcine circovirus type 2. In studies to date, N2-01 has been shown to significantly reduce endothelial dysfunction and vascular leakage in human endothelial cells.Based in Edinburgh, N2 Pharmaceuticals intend to repurpose N2-01 from animal health applications to treat a number of acute human diseases associated with endothelial dysfunction.
EDUCATION
Alliance Manchester Business School
BA (Hons), International Business, Finance and Economics
SKILLS
ABOUT NATALIA ROMANOVA
I am a highly driven and experienced business development specialist with a strong…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.